38104182|t|Chia seeds oil ameliorate chronic immobilization stress-induced neurodisturbance in rat brains via activation of the antioxidant/anti-inflammatory/antiapoptotic signaling pathways.
38104182|a|Chronic immobilization stress plays a key role in several neuropsychiatric disorders. This investigation assessed the possible ameliorative effect of chia seed oil (CSO) against the neurodisturbance-induced in rats by chronic immobilization. Rats were randomly allocated into control, CSO (1 ml/kg b.wt./orally), restrained (6 h/day), CSO pre-restraint, and CSO post-restraint for 60 days. Results revealed a significant reduction in serum corticosterone level, gene expression of corticotrophin-releasing factor, pro-inflammatory cytokines, and oxidative biomarkers in restrained rats treated with CSO. The histopathological findings revealed restoring necrosis and neuronal loss in CSO-treated-restraint rats. The immunohistochemical evaluation revealed a significant reduction in the immuno-expression of caspase-3, nuclear factor kappa B, interleukin-6, and cyclooxygenase-2 (COX-2), and an elevation of calbindin-28k and synaptophysin expression compared to non-treated restraint rats. The molecular docking showed the CSO high affinity for several target proteins, including caspase-3, COX-2, corticotropin-releasing hormone binding protein, corticotropin-releasing factor receptors 1 and 2, interleukin-1 receptor types 1 and 2, interleukin-6 receptor subunits alpha and beta. In conclusion, CSO emerges as a promising candidate against stress-induced brain disruptions by suppressing inflammatory/oxidative/apoptotic signaling pathways due to its numerous antioxidant and anti-inflammatory components, mainly alpha-linolenic acid. Future studies are necessary to evaluate the CSO therapeutic impacts in human neurodisturbances.
38104182	0	14	Chia seeds oil	Chemical	-
38104182	64	80	neurodisturbance	Disease	
38104182	84	87	rat	Species	10116
38104182	134	146	inflammatory	Disease	MESH:D007249
38104182	239	265	neuropsychiatric disorders	Disease	MESH:D001523
38104182	331	344	chia seed oil	Chemical	-
38104182	346	349	CSO	Chemical	-
38104182	363	379	neurodisturbance	Disease	
38104182	391	395	rats	Species	10116
38104182	423	427	Rats	Species	10116
38104182	466	469	CSO	Chemical	-
38104182	516	519	CSO	Chemical	-
38104182	539	542	CSO	Chemical	-
38104182	621	635	corticosterone	Chemical	MESH:D003345
38104182	699	711	inflammatory	Disease	MESH:D007249
38104182	762	766	rats	Species	10116
38104182	780	783	CSO	Chemical	-
38104182	835	843	necrosis	Disease	MESH:D009336
38104182	848	861	neuronal loss	Disease	MESH:D009410
38104182	865	868	CSO	Chemical	-
38104182	887	891	rats	Species	10116
38104182	989	998	caspase-3	Gene	25402
38104182	1024	1037	interleukin-6	Gene	24498
38104182	1043	1059	cyclooxygenase-2	Gene	29527
38104182	1061	1066	COX-2	Gene	29527
38104182	1107	1120	synaptophysin	Gene	24804
38104182	1166	1170	rats	Species	10116
38104182	1205	1208	CSO	Chemical	-
38104182	1262	1271	caspase-3	Gene	25402
38104182	1273	1278	COX-2	Gene	29527
38104182	1280	1327	corticotropin-releasing hormone binding protein	Gene	29625
38104182	1480	1483	CSO	Chemical	-
38104182	1540	1557	brain disruptions	Disease	MESH:D019958
38104182	1573	1585	inflammatory	Disease	MESH:D007249
38104182	1666	1678	inflammatory	Disease	MESH:D007249
38104182	1698	1718	alpha-linolenic acid	Chemical	MESH:D017962
38104182	1765	1768	CSO	Chemical	-
38104182	1792	1797	human	Species	9606
38104182	1798	1815	neurodisturbances	Disease	
38104182	Negative_Correlation	MESH:D017962	MESH:D007249
38104182	Negative_Correlation	MESH:D017962	MESH:D019958

